Literature DB >> 14152276

6-THIOGUANINE (NSC-752)-1 THERAPY IN PATIENTS WITH MULTIPLE MYELOMA.

P P CARBONE, E FREI, A H OWENS, K B OLSON, S P MILLER.   

Abstract

Entities:  

Keywords:  ALKYLATING AGENTS; ANTINEOPLASTIC AGENTS; BLOOD CHEMICAL ANALYSIS; BONE MARROW; CLINICAL RESEARCH; GAMMA GLOBULIN; GERIATRICS; MULTIPLE MYELOMA; THIOGUANINE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14152276

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  2 in total

Review 1.  6-thioguanine: a drug with unrealized potential for cancer therapy.

Authors:  Pashna N Munshi; Martin Lubin; Joseph R Bertino
Journal:  Oncologist       Date:  2014-06-13

2.  A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group study.

Authors:  M B Edelstein; J J Crowley; F A Valeriote; J D Bonnet; J O Carden; R C Khanna; S E Salmon; J S Ungerleider
Journal:  Invest New Drugs       Date:  1990       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.